Bronchiectasis Clinical Trials

91 recruitingLast updated: June 17, 2026

There are 91 actively recruiting bronchiectasis clinical trials across 52 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1. Top locations include London, United Kingdom, Wuhan, Hubei, China, Shanghai, Shanghai Municipality, China. Updated daily from ClinicalTrials.gov.


Bronchiectasis Trials at a Glance

91 actively recruiting trials for bronchiectasis are listed on ClinicalTrialsFinder across 6 cities in 52 countries. The largest study group is Not Applicable with 22 trials, with the heaviest enrollment activity in London, Wuhan, and Shanghai. Lead sponsors running bronchiectasis studies include Assiut University, Mayo Clinic, and Shanghai Pulmonary Hospital, Shanghai, China.

Browse bronchiectasis trials by phase

Treatments under study

About Bronchiectasis Clinical Trials

Looking for clinical trials for Bronchiectasis? There are currently 91 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bronchiectasis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bronchiectasis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 91 trials

Recruiting

A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

Non-cystic Fibrosis Bronchiectasis
AstraZeneca320 enrolled38 locationsNCT07245407
Recruiting

Bronchi Dilation in Polynesian Patients: Monocentric Retrospective Study

Polynesian Bronchiectasis
Centre Hospitalier Intercommunal Creteil500 enrolled1 locationNCT04798950
Recruiting
Phase 2

A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis
Sanofi70 enrolled3 locationsNCT07547436
Recruiting
Not Applicable

Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease

BronchiectasisNontuberculous Mycobacterial Lung Disease
Taipei Veterans General Hospital, Taiwan262 enrolled1 locationNCT07647575
Recruiting

Breathlessness Perceptions Within Respiratory Diseases

Chronic Obstructive Pulmonary Disease (COPD)BronchiectasisAsthma (Diagnosis)+2 more
University Hospitals, Leicester75 enrolled1 locationNCT07648082
Recruiting
Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Bronchiectasis
Boehringer Ingelheim1,755 enrolled494 locationsNCT06872892
Recruiting
Phase 2

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

Bronchiectasis
GlaxoSmithKline446 enrolled39 locationsNCT07201051
Recruiting
Not Applicable

Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis
Physio-Assist622 enrolled57 locationsNCT06487273
Recruiting
Phase 1

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

Chronic Obstructive Pulmonary DiseaseNon-cystic Fibrosis Bronchiectasis
Genentech, Inc.128 enrolled7 locationsNCT06603246
Recruiting
Phase 2

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Bronchiectasis With Pseudomonas Aeruginosa Colonization
AstraZeneca435 enrolled185 locationsNCT07088926
Recruiting
Phase 4

Itraconazole Therapy In Bronchiectasis With Airway Mold

BronchiectasisFungal Infection of Upper Respiratory Tract
Mayo Clinic30 enrolled1 locationNCT07283497
Recruiting
Phase 3

A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis
Haisco Pharmaceutical Group Co., Ltd.669 enrolled1 locationNCT07616375
Recruiting

Bronchiectasis Phenotype Identification Model

BronchiectasisBronchiectasis with Acute ExacerbationNon-cystic Fibrosis Bronchiectasis
Assiut University750 enrolled1 locationNCT07599969
Recruiting

BASE: Bronchiectasis Severity and Exacerbation Risk Study

BronchiectasisBronchiectasis with Acute ExacerbationNon-cystic Fibrosis Bronchiectasis
Assiut University750 enrolled1 locationNCT07599839
Recruiting

Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)

BronchiectasisNon-Tuberculous Mycobacteria Pulmonary Disease
University College, London80 enrolled1 locationNCT07192705
Recruiting

Study of Bronchiectasis and Associated Cardiovascular Comorbidities

Bronchiectasis
Assiut University30 enrolled1 locationNCT05783869
Recruiting
Phase 2

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA284 enrolled51 locationsNCT06559150
Recruiting

Investigating the use of humidified high flow therapy (supplemental oxygen optional) in the home setting for patients with existing lung disease (Chronic Obstructive Pulmonary Disease (COPD) or Bronchiectasis). The DOMINO Study

Chronic Obstructive Pulmonary Disease (COPD)Bronchiectasis
Metro North Hospital and Health Services60 enrolled2 locationsACTRN12626000558325
Recruiting

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

PneumothoraxCOPDPneumonia+4 more
Assiut University700 enrolled1 locationNCT06983366
Recruiting

HFNC in Management of Bronchiectasis Exacerbation

Bronchiectasis
Assiut University20 enrolled1 locationNCT05741697